Synovus EVP buys 1,000 SNV shares at $47.79 – insider Form 4 filing
Synovus Financial Corp. (SNV) Form 4: EVP & Chief Risk Officer Shellie Creson purchased 1,000 common shares on 08/05/2025 at $47.79 (code “P”).
Rhea-AI Filing Summary
Synovus Financial Corp. (SNV) Form 4: EVP & Chief Risk Officer Shellie Creson purchased 1,000 common shares on 08/05/2025 at $47.79 (code “P”). Following the open-market buy, Creson directly owns 27,258 shares. No derivative trades were reported.
The ~$48k purchase represents a modest vote of confidence from a senior executive but is financially immaterial relative to Synovus’s market capitalization and is unlikely to move the stock on its own.
Positive
- Insider purchase: Senior officer bought 1,000 shares, indicating personal confidence.
Negative
- Low dollar amount: ~$48k is insignificant versus Synovus’s market cap, limiting signal strength.
Insights
TL;DR: Minor insider buy; positive sentiment, negligible valuation impact.
An EVP buying 1,000 shares is directionally bullish, suggesting management’s confidence after recent market activity. However, at under $50k, the purchase equals a fraction of daily trading volume and does not materially alter insider ownership percentages. Investors may view it as a soft, longer-term signal rather than an actionable catalyst.
TL;DR: Routine disclosure, no governance red flags detected.
The filing is timely, properly signed, and shows compliance with Section 16 reporting. No 10b5-1 plan was cited, indicating discretionary buying. The transaction aligns with sound governance practices but its small size limits informational value. Overall impact: neutral.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,000 | $47.79 | $48K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Was the purchase made under a Rule 10b5-1 trading plan?
Why is Form 4 important to investors?
AI-generated analysis. How Rhea-AI works. Not financial advice.